BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35562311)

  • 1. Differential efficacy of ablation therapy versus partial nephrectomy between clinical T1a and T1b renal tumors: A systematic review and meta-analysis.
    Yanagisawa T; Mori K; Kawada T; Motlagh RS; Mostafaei H; Quhal F; Laukhtina E; Rajwa P; Aydh A; König F; Pallauf M; Pradere B; Miki J; Kimura T; Egawa S; Shariat SF
    Urol Oncol; 2022 Jul; 40(7):315-330. PubMed ID: 35562311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
    Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
    Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryoablation versus Partial Nephrectomy for Clinical T1b Renal Tumors: A Matched Group Comparative Analysis.
    Caputo PA; Zargar H; Ramirez D; Andrade HS; Akca O; Gao T; Kaouk JH
    Eur Urol; 2017 Jan; 71(1):111-117. PubMed ID: 27568064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous cryoablation versus partial nephrectomy for cT1b renal tumors: An inverse probability weight analysis.
    Aikawa K; Yanagisawa T; Fukuokaya W; Shimizu K; Miyajima K; Nakazono M; Iwatani K; Matsukawa A; Obayashi K; Kimura S; Tsuzuki S; Sasaki H; Abe H; Sadaoka S; Miki J; Kimura T
    Urol Oncol; 2023 Mar; 41(3):150.e11-150.e19. PubMed ID: 36604229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization and quality outcomes of cT1a, cT1b and cT2a partial nephrectomy: analysis of the national cancer database.
    Fero K; Hamilton ZA; Bindayi A; Murphy JD; Derweesh IH
    BJU Int; 2018 Apr; 121(4):565-574. PubMed ID: 29032581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of overall survival and perioperative outcomes between partial and radical nephrectomy for cT1b and cT2 renal cell carcinoma-Analysis of a national cancer registry.
    Venkatramani V; Koru-Sengul T; Miao F; Nahar B; Prakash NS; Swain S; Punnen S; Ritch C; Gonzalgo M; Parekh D
    Urol Oncol; 2018 Mar; 36(3):90.e9-90.e14. PubMed ID: 29254672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of perioperative outcomes of robot-assisted partial nephrectomy without renorrhaphy: Comparative outcomes of cT1a versus cT1b renal tumors.
    Tohi Y; Murata S; Makita N; Suzuki I; Kubota M; Sugino Y; Inoue K; Kawakita M
    Int J Urol; 2019 Sep; 26(9):885-889. PubMed ID: 31257682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care.
    Sterling J; Rivera-Núñez Z; Patel HV; Farber NJ; Kim S; Radadia KD; Modi PK; Goyal S; Parikh R; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
    Clin Genitourin Cancer; 2020 Dec; 18(6):e643-e650. PubMed ID: 32389458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Long-term Outcomes for Young and Healthy Patients with cT1a and cT3a Renal Cell Carcinoma Treated with Partial Nephrectomy.
    Tan WS; Koelker M; Campain N; Cole AP; Labban M; Mossanen M; Barod R; Kibel AS; Chang SL; Bex A; Trinh QD
    Eur Urol Focus; 2023 Mar; 9(2):333-335. PubMed ID: 36241545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing Outcomes for Patients with Clinical T1b Renal Cell Carcinoma Treated With Either Percutaneous Microwave Ablation or Surgery.
    Shapiro DD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Jarrard DF; Richards KA; Downs TM; Allen GO; Nakada SY; Abel EJ
    Urology; 2020 Jan; 135():88-94. PubMed ID: 31585198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robot-assisted partial nephrectomy for large renal masses: a multi-institutional series.
    Delto JC; Paulucci D; Helbig MW; Badani KK; Eun D; Porter J; Abaza R; Hemal AK; Bhandari A
    BJU Int; 2018 Jun; 121(6):908-915. PubMed ID: 29357404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Ablation Versus Robotic Partial Nephrectomy in the Treatment of cT1b Renal Tumors: Oncologic and Functional Outcomes of a Propensity Score-weighted Analysis.
    Rembeyo G; Correas JM; Jantzen R; Audenet F; Dariane C; Delavaud C; Mejean A; Timsit MO
    Clin Genitourin Cancer; 2020 Apr; 18(2):138-147. PubMed ID: 31982346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results from the Canadian Kidney Cancer Information System.
    Millan B; Breau RH; Bhindi B; Mallick R; Tanguay S; Finelli A; Lavallée LT; Pouliot F; Rendon R; So AI; Dean L; Lattouf JB; Basappa NS; Kapoor A
    J Urol; 2022 Oct; 208(4):804-812. PubMed ID: 35686812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients.
    Yu J; Zhang X; Liu H; Zhang R; Yu X; Cheng Z; Han Z; Liu F; Hao G; Mu MJ; Liang P
    Radiology; 2020 Mar; 294(3):698-706. PubMed ID: 31961239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablative therapies versus partial nephrectomy for small renal masses - A systematic review and meta-analysis.
    Chan VW; Abul A; Osman FH; Ng HH; Wang K; Yuan Y; Cartledge J; Wah TM
    Int J Surg; 2022 Jan; 97():106194. PubMed ID: 34958968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial Nephrectomy versus Thermal Ablation for Clinical Stage T1 Renal Masses: Systematic Review and Meta-Analysis of More than 3,900 Patients.
    Rivero JR; De La Cerda J; Wang H; Liss MA; Farrell AM; Rodriguez R; Suri R; Kaushik D
    J Vasc Interv Radiol; 2018 Jan; 29(1):18-29. PubMed ID: 29102464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial nephrectomy versus ablative therapies for cT1a renal masses: A Systematic Review and meta-analysis.
    Hu X; Shao YX; Wang Y; Yang ZQ; Yang WX; Li X
    Eur J Surg Oncol; 2019 Sep; 45(9):1527-1535. PubMed ID: 31171480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous ablation or minimally invasive partial nephrectomy for cT1a renal masses? A propensity score-matched analysis.
    Bianchi L; Chessa F; Piazza P; Ercolino A; Mottaran A; Recenti D; Serra C; Gaudiano C; Cappelli A; Modestino F; Golfieri R; Bertaccini A; Marcelli E; Porreca A; Celia A; Schiavina R
    Int J Urol; 2022 Mar; 29(3):222-228. PubMed ID: 34894001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.